These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

387 related items for PubMed ID: 19666909

  • 1. Effect of the cGMP pathway on AQP2 expression and translocation: potential implications for nephrogenic diabetes insipidus.
    Boone M, Kortenoeven M, Robben JH, Deen PM.
    Nephrol Dial Transplant; 2010 Jan; 25(1):48-54. PubMed ID: 19666909
    [Abstract] [Full Text] [Related]

  • 2. Development of lithium-induced nephrogenic diabetes insipidus is dissociated from adenylyl cyclase activity.
    Li Y, Shaw S, Kamsteeg EJ, Vandewalle A, Deen PM.
    J Am Soc Nephrol; 2006 Apr; 17(4):1063-72. PubMed ID: 16495377
    [Abstract] [Full Text] [Related]

  • 3. Regulation of aquaporin-2 trafficking.
    Nedvetsky PI, Tamma G, Beulshausen S, Valenti G, Rosenthal W, Klussmann E.
    Handb Exp Pharmacol; 2009 Apr; (190):133-57. PubMed ID: 19096775
    [Abstract] [Full Text] [Related]

  • 4. Stimulation of AQP2 membrane insertion in renal epithelial cells in vitro and in vivo by the cGMP phosphodiesterase inhibitor sildenafil citrate (Viagra).
    Bouley R, Pastor-Soler N, Cohen O, McLaughlin M, Breton S, Brown D.
    Am J Physiol Renal Physiol; 2005 Jun; 288(6):F1103-12. PubMed ID: 15644488
    [Abstract] [Full Text] [Related]

  • 5. Methyl-beta-cyclodextrin induces vasopressin-independent apical accumulation of aquaporin-2 in the isolated, perfused rat kidney.
    Russo LM, McKee M, Brown D.
    Am J Physiol Renal Physiol; 2006 Jul; 291(1):F246-53. PubMed ID: 16449354
    [Abstract] [Full Text] [Related]

  • 6. p.R254Q mutation in the aquaporin-2 water channel causing dominant nephrogenic diabetes insipidus is due to a lack of arginine vasopressin-induced phosphorylation.
    Savelkoul PJ, De Mattia F, Li Y, Kamsteeg EJ, Konings IB, van der Sluijs P, Deen PM.
    Hum Mutat; 2009 Oct; 30(10):E891-903. PubMed ID: 19585583
    [Abstract] [Full Text] [Related]

  • 7. In mpkCCD cells, long-term regulation of aquaporin-2 by vasopressin occurs independent of protein kinase A and CREB but may involve Epac.
    Kortenoeven ML, Trimpert C, van den Brand M, Li Y, Wetzels JF, Deen PM.
    Am J Physiol Renal Physiol; 2012 Jun 01; 302(11):F1395-401. PubMed ID: 22419689
    [Abstract] [Full Text] [Related]

  • 8. Lack of arginine vasopressin-induced phosphorylation of aquaporin-2 mutant AQP2-R254L explains dominant nephrogenic diabetes insipidus.
    de Mattia F, Savelkoul PJ, Kamsteeg EJ, Konings IB, van der Sluijs P, Mallmann R, Oksche A, Deen PM.
    J Am Soc Nephrol; 2005 Oct 01; 16(10):2872-80. PubMed ID: 16120822
    [Abstract] [Full Text] [Related]

  • 9. PKD1 haploinsufficiency causes a syndrome of inappropriate antidiuresis in mice.
    Ahrabi AK, Terryn S, Valenti G, Caron N, Serradeil-Le Gal C, Raufaste D, Nielsen S, Horie S, Verbavatz JM, Devuyst O.
    J Am Soc Nephrol; 2007 Jun 01; 18(6):1740-53. PubMed ID: 17475819
    [Abstract] [Full Text] [Related]

  • 10. Atrial natriuretic peptide and nitric oxide signaling antagonizes vasopressin-mediated water permeability in inner medullary collecting duct cells.
    Klokkers J, Langehanenberg P, Kemper B, Kosmeier S, von Bally G, Riethmüller C, Wunder F, Sindic A, Pavenstädt H, Schlatter E, Edemir B.
    Am J Physiol Renal Physiol; 2009 Sep 01; 297(3):F693-703. PubMed ID: 19570884
    [Abstract] [Full Text] [Related]

  • 11. AKAPs-PKA disruptors increase AQP2 activity independently of vasopressin in a model of nephrogenic diabetes insipidus.
    Ando F, Mori S, Yui N, Morimoto T, Nomura N, Sohara E, Rai T, Sasaki S, Kondo Y, Kagechika H, Uchida S.
    Nat Commun; 2018 Apr 12; 9(1):1411. PubMed ID: 29650969
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Nephrogenic diabetes insipidus.
    Bichet DG.
    Adv Chronic Kidney Dis; 2006 Apr 12; 13(2):96-104. PubMed ID: 16580609
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Potential of nonpeptide (ant)agonists to rescue vasopressin V2 receptor mutants for the treatment of X-linked nephrogenic diabetes insipidus.
    Los EL, Deen PM, Robben JH.
    J Neuroendocrinol; 2010 May 12; 22(5):393-9. PubMed ID: 20163515
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. P2Y12 Receptor Localizes in the Renal Collecting Duct and Its Blockade Augments Arginine Vasopressin Action and Alleviates Nephrogenic Diabetes Insipidus.
    Zhang Y, Peti-Peterdi J, Müller CE, Carlson NG, Baqi Y, Strasburg DL, Heiney KM, Villanueva K, Kohan DE, Kishore BK.
    J Am Soc Nephrol; 2015 Dec 12; 26(12):2978-87. PubMed ID: 25855780
    [Abstract] [Full Text] [Related]

  • 20. Congenital nephrogenic diabetes insipidus: what can we learn from mouse models?
    Boone M, Deen PM.
    Exp Physiol; 2009 Feb 12; 94(2):186-90. PubMed ID: 18790812
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 20.